Key Statistics
Market Cap$6.54M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.30
52W High$5.48
52W Low$1.67
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week-1.68%
3 Month-10.40%
1 Year-30.57%
FinancialsAnnual · QuiverQuant
Revenue$5,000
Assets$8.26M
Liabilities$1.96M
Net Income$35.14M loss
About
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze TCRT with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.